Marksans Pharma soars as UK MHRA finds no critical observations at Goa unit
The stock surged 20% to Rs 48.70 on the BSE in intra-day trade on back of heavy volumes.
 "Capsules")
premium
Capsules
Marksan Pharma surged 20% to Rs 49 on the BSE in intra-day trade after the company said UK health regulator has completed the inspection of Goa unit without any critical observations.
“The Company's plant located at L-82 & L-83, Verna Industrial Estate, Verna, Goa - 403 722 has had an inspection by UK Medicines and Healthcare products Regulatory Agency (MHRA) from February 14, 2017 to February 17, 2017,” Marksans Pharma said in a exchanges filing.
The same has been completed without any critical observations, it added.
The company said it is awaiting further instructions from the agency in this regard.
At 12:43 pm; the stock was up 19.5% at Rs 48.50 on back of over 10-fold jump in trading volumes. A combined 37.42 million shares representing 9% of total equity of Marksans Pharma changed hands on the counter on the BSE and NSE.
“The Company's plant located at L-82 & L-83, Verna Industrial Estate, Verna, Goa - 403 722 has had an inspection by UK Medicines and Healthcare products Regulatory Agency (MHRA) from February 14, 2017 to February 17, 2017,” Marksans Pharma said in a exchanges filing.
The same has been completed without any critical observations, it added.
The company said it is awaiting further instructions from the agency in this regard.
At 12:43 pm; the stock was up 19.5% at Rs 48.50 on back of over 10-fold jump in trading volumes. A combined 37.42 million shares representing 9% of total equity of Marksans Pharma changed hands on the counter on the BSE and NSE.